Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial ( ATTR‐ACT ) and long‐term extension study

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

Wiley

Online

2020-10-18

DOI

10.1002/ejhf.2027

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started